ArticleRSC advances2026
Curcumin release from hydrogels incorporated with turmeric extract-cyclodextrin complexes for wound dressing applications.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multifunctional Silk Fibroin-Curcuminoid Films Combining Regenerative and Antioxidant Properties with pH Sensing for Wound Dressing Applications.Biomimetics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin, the major bioactive compound of turmeric, exhibits potent antioxidant and anti-inflammatory activities with significant therapeutic potential for wound healing. However, its clinical use is hindered by inherently poor water solubility. In this study, cyclodextrin (CD) inclusion complexes were prepared with turmeric extract (TE) to enhance the aqueous solubility and release of curcumin from hydrogels intended as active wound dressings. The TE-to-CD ratio was systematically varied from 10-80% (w/w), yielding complexes designated as 10TECD-80TECD formulations. Formulations below 20TECD exhibited superior aqueous solubility while retaining antioxidant activity. SEM analysis showed a morphological transition from large (∼5 µm) to smaller (∼1 µm) flake-like particles in formulations below 40TECD. The TECD complexes were subsequently incorporated into hydrogel sheets prepared from 3-8% (w/v) poly(vinyl alcohol) (PVA), which were crosslinked by freeze-thaw cycling followed by electron beam irradiation. Curcumin release was inversely related to PVA concentration, with the lowest concentration producing the most porous matrix structure and greatest surface area, thereby facilitating the highest release. The optimized formulation, consisting of a 3PVA hydrogel loaded with 20TECD, achieved a cumulative curcumin release of 13.25% within 6 h, with release characteristics consistent with Fickian diffusion kinetics. The system exhibited no cytotoxicity and also showed anti-inflammatory activity as confirmed by nitric oxide inhibition assay. These findings highlight the potential of TECD-loaded PVA hydrogels as effective bioactive wound dressing materials for curcumin delivery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.